Tekla Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $6.47M | Hold |
93,621
| – | – | 0.25% | 74 |
|
|
2023
Q1 | $6.96M | Hold |
93,621
| – | – | 0.26% | 67 |
|
|
2022
Q4 | $8.72M | Sell |
93,621
-30,182
| -24% | -$2.91M | 0.33% | 61 |
|
|
2022
Q3 | $11.8M | Hold |
123,803
| – | – | 0.48% | 49 |
|
|
2022
Q2 | $11.5M | Sell |
123,803
-23,650
| -16% | -$2.31M | 0.45% | 56 |
|
|
2022
Q1 | $14.9M | Hold |
147,453
| – | – | 0.52% | 52 |
|
|
2021
Q4 | $15.2M | Hold |
147,453
| – | – | 0.49% | 50 |
|
|
2021
Q3 | $12.5M | Hold |
147,453
| – | – | 0.4% | 60 |
|
|
2021
Q2 | $12.3M | Sell |
147,453
-72,542
| -33% | -$5.94M | 0.4% | 64 |
|
|
2021
Q1 | $16.6M | Hold |
219,995
| – | – | 0.57% | 47 |
|
|
2020
Q4 | $15M | Sell |
219,995
-168,268
| -43% | -$10.9M | 0.53% | 56 |
|
|
2020
Q3 | $22.7M | Sell |
388,263
-331,357
| -46% | -$20.6M | 0.85% | 31 |
|
|
2020
Q2 | $46.8M | Buy |
719,620
+221,634
| +45% | +$14M | 1.78% | 13 |
|
|
2020
Q1 | $29.5M | Hold |
497,986
| – | – | 1.34% | 18 |
|
|
2019
Q4 | $37M | Sell |
497,986
-42,300
| -8% | -$2.97M | 1.4% | 17 |
|
|
2019
Q3 | $34.1M | Sell |
540,286
-35,115
| -6% | -$2.08M | 1.49% | 15 |
|
|
2019
Q2 | $31.4M | Buy |
575,401
+69,037
| +14% | +$3.72M | 1.28% | 18 |
|
|
2019
Q1 | $27.3M | Buy |
506,364
+45,666
| +10% | +$2.82M | 1.11% | 21 |
|
|
2018
Q4 | $30.2M | Buy |
460,698
+59,597
| +15% | +$4.45M | 1.29% | 21 |
|
|
2018
Q3 | $31.6M | Buy |
401,101
+34,580
| +9% | +$2.47M | 1.15% | 21 |
|
|
2018
Q2 | $23.6M | Hold |
366,521
| – | – | 0.9% | 30 |
|
|
2018
Q1 | $22.8M | Hold |
366,521
| – | – | 0.89% | 28 |
|
|
2017
Q4 | $26.6M | Sell |
366,521
-45,370
| -11% | -$3.3M | 1.02% | 25 |
|
|
2017
Q3 | $33.5M | Hold |
411,891
| – | – | 1.2% | 23 |
|
|
2017
Q2 | $33.1M | Hold |
411,891
| – | – | 1.23% | 23 |
|
|
2017
Q1 | $32.3M | Hold |
411,891
| – | – | 1.25% | 24 |
|
|
2016
Q4 | $32.5M | Hold |
411,891
| – | – | 1.38% | 22 |
|
|
2016
Q3 | $36.7M | Buy |
411,891
+188,000
| +84% | +$17.7M | 1.41% | 22 |
|
|
2016
Q2 | $21.4M | Buy |
+223,891
| New | +$22.3M | 0.87% | 31 |
|
|
2014
Q1 | – | Sell |
-53,694
| Closed | -$3.84M | – | 62 |
|
|
2013
Q4 | $3.84M | Hold |
53,694
| – | – | 0.4% | 41 |
|
|
2013
Q3 | $3.05M | Sell |
53,694
-17,897
| -25% | -$1.07M | 0.34% | 52 |
|
|
2013
Q2 | $4.09M | Buy |
+71,591
| New | +$4.15M | 0.56% | 44 |
|
Other funds holding CVS
Tekla Capital Management's CVS Position: Q2 2023 in Review
Tekla Capital Management held its CVS Health (CVS) position steady in Q2 2023 at 93,621 shares worth $6.47M. The position accounts for 0.25% of the portfolio, ranked #74.
Tekla Capital Management first reported a position in CVS in Q2 2013 and has held it in 32 quarters since. The position peaked at $46.8M in Q2 2020. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.
- Tekla Capital Management held 93,621 shares of CVS Health worth $6.47M as of Q2 2023.
- Tekla Capital Management left its CVS Health share count unchanged in Q2 2023.
- CVS Health made up 0.25% of Tekla Capital Management's portfolio in Q2 2023, its #74 holding.
- Tekla Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 32 quarters since.
- Tekla Capital Management's CVS Health position peaked at $46.8M in Q2 2020.
- 2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.
Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.